TY  - CONF

T1  - LABORATORY SAFETY OF DUPILUMAB IN PEDIATRIC PATIENTS AGED >= 6-< 12 YEARS WITH SEVERE ATOPIC DERMATITIS: RESULTS FROM A PHASE 3 TRIAL (LIBERTY AD PEDS)

JO  - ACTA DERMATO-VENEREOLOGICA

PY  - 2021/01/01

AU  - Wollenberg A

AU  - Thaci D

AU  - Cork MJ

AU  - Arkwright PD

AU  - Gooderham M

AU  - Sun X

AU  - O'Malley JT

AU  - Khokhar FA

AU  - Bansal A

AU  - Shumel B

ED  - 

VL  - 101

SP  - 59

EP  - 59

Y2  - 2024/12/22

ER  -